trans-1,2-dihydro-1,2-naphthalenediol has been researched along with benzo(a)pyrene 7,8-dihydrodiol in 1 studies
| Studies (trans-1,2-dihydro-1,2-naphthalenediol) | Trials (trans-1,2-dihydro-1,2-naphthalenediol) | Recent Studies (post-2010) (trans-1,2-dihydro-1,2-naphthalenediol) | Studies (benzo(a)pyrene 7,8-dihydrodiol) | Trials (benzo(a)pyrene 7,8-dihydrodiol) | Recent Studies (post-2010) (benzo(a)pyrene 7,8-dihydrodiol) |
|---|---|---|---|---|---|
| 29 | 0 | 15 | 214 | 0 | 5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Doehmer, J; Jacob, J; Kabler, SL; Morrow, CS; Seidel, A; Townsend, AJ | 1 |
1 other study(ies) available for trans-1,2-dihydro-1,2-naphthalenediol and benzo(a)pyrene 7,8-dihydrodiol
| Article | Year |
|---|---|
Differential protection by human glutathione S-transferase P1 against cytotoxicity of benzo[a]pyrene, dibenzo[a,l]pyrene, or their dihydrodiol metabolites, in bi-transgenic cell lines that co-express rat versus human cytochrome P4501A1.
Topics: Animals; Benzo(a)pyrene; Cell Proliferation; Cells, Cultured; Cytochrome P-450 CYP1A1; Dihydroxydihydrobenzopyrenes; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Glutathione S-Transferase pi; Humans; Naphthalenes; Rats; Transgenes | 2009 |